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Incapacitating and irritating agents produce temporary disability persisting for hours to days 
after the exposure. One can be exposed to these agents occupationally in industrial or other 
working environments. Also general public can be exposed in special circumstances, like 
industrial accidents or riots. Incapacitating and irritating agents discussed in this review are 
chloropicrin and capsaicinoids. In addition, we include sulfur mustard, which is an old chemical 
warfare agent and known to cause severe long-lasting injuries or even death. Chloropicrin 
that was used as a warfare agent in the World War I is currently used mainly as a pesticide. 
Capsaicinoids, components of hot pepper plants, are used by police and other law enforcement 
personnel as riot control agents. Toxicity of these chemicals is associated particularly with the 
respiratory tract, eyes, and skin.  Their acute effects are relatively well known but the knowledge 
of putative long-term effects is almost non-existent. Also, mechanisms of effects at cellular 
level are not fully understood. There is a need for further research to get better idea of health 
risks, particularly of long-term and low-level exposures to these chemicals. For this, exposure 
biomarkers are essential. Validated exposure biomarkers for capsaicinoids, chloropicrin, and sulfur 
mustard do not exist so far. Metabolites and macromolecular adducts have been suggested 
biomarkers for sulfur mustard and these can already be measured qualitatively, but quantitative 
biomarkers await further development and validation. The purpose of this review is, based on 
the existing mechanistic and toxicokinetic information, to shed light on the possibilities for 
developing biomarkers for exposure biomonitoring of these compounds. It is also of interest 
to find ideas for early effect biomarkers considering the need for studies on subchronic and 
chronic toxicity.
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used as a pesticide. Capsaicinoids are used by police and soldiers as 
riot control agents. Although acute effects of these compounds are 
relatively well known, knowledge of their putative long-term effects 
is almost non-existent. Also mechanisms of action at cellular level 
are not fully understood. The recent follow-up of Iranian victims 
has revealed long-term debilitating diseases of the lungs, eyes, and 
skin after expose to sulfur mustard (Balali-Mood and Hefazi, 2006). 
Similar long-term health effects have been described for some other 
warfare agents (Volans and Karalliedde, 2002) and the possibility 
for toxic effects by any chemical after chronic exposure needs to 
be taken on account.
There is an urgent need for the development and use of biomark-
ers in order to assess human exposures to these chemicals at occu-
pational or other occasions. Exposure biomarkers that measure 
internal exposure or dose provide more reliable data to establish 
the link between possible adverse health effects and exposures 
than traditional measurements from environmental, e.g., from 
air or food (Watson and Mutti, 2004). The application of specific 
exposure biomarkers is of critical importance in the detection of 
high acute exposure at accidental or military situations in order 
INTRODUCTION
Incapacitating and irritating agents produce temporary disabil-
ity persisting for hours to days after the exposure. Occupational 
exposure to incapacitating and irritating chemicals may occur in 
industry or in other work environment (e.g., transportation, stock-
piling). Also general public may be exposed to these compounds 
in special circumstances, like during riots or industrial accidents. 
A terrorist attack with chemical agents is a more likely threat than 
exposure in military open battlefields. Exposure in buildings or 
other confined spaces with limited air conditioning may result in 
serious injury or death as concentrations may rise substantially 
high. Personnel working in crisis managements may repeatedly be 
exposed to low concentrations of different hazardous chemicals of 
unknown origin.
Sulfur  mustard,  chloropicrin,  and  capsaicinoids  have  been 
selected into this review because they represent chemically diverse 
irritating and incapacitating agents, with various modes of action. 
Sulfur mustard is an old chemical warfare agent (CWA) and the 
exposure to this vesicant has caused human casualties. Chloropicrin 
was used as a CWA during the World War I and is nowadays mainly 
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riot control weapons. Capsaicinoids containing sprays are utilized 
by the police or other low enforcement personnel to temporally 
incapacitate violent and rebellious individuals (Busker and van 
Helden, 1998). Capsaicinoids are known to act particularly on the 
small afferent sensory neurons but also on non-neuronal tissues. 
Irritation and burning pain are especially perceived in the skin, 
eyes, nose, tongue, and the respiratory tract or generally in the 
tissues where a number of sensory nerve fibers terminate. Due to 
causing intense pain, uncontrolled coughing, and temporary loss 
of vision, exposed individuals are easily captured (Watson et al., 
1996; Busker and van Helden, 1998).
Capsaicinoids  are  pharmacologically  active  compounds, 
which have been shown to elicit multiple effects in humans 
and experimental animals (Szallasi and Blumberg, 1999). Most 
studies concerning pharmacological properties and toxicity of 
capsaicinoids have been conducted using capsaicin. There are 
only a few studies done using other capsaicinoid analogs or 
mixture of analogs. According to the available literature, the 
adverse effects and toxicity are not generally high, but the use 
of these compounds is not entirely without risk. The risk for 
toxicity increases with higher exposure levels and prolonged 
exposure. Several cases of poisoning and fatalities have been 
reported particularly following the use of the pepper gas spray 
even though it has been regarded as “a relative safe weapon” 
(Miller, 1996; Watson et al., 1996; Busker and van Helden, 1998; 
Snyman et al., 2001; Smith and Greaves, 2002). In such cases 
the patients have suffered from airway obstructions and respi-
ratory arrest after inhaling pepper products (Busker and van 
Helden, 1998).
to ensure rapid medical aid. In addition, sensitive and accurate 
biomarkers of exposure would be even more critical when moni-
toring low-level exposures in connection with chronic effects in 
follow-up studies.
Our purpose is, based on the existing mechanistic and toxicoki-
netic information, to review data about existing ideas of biomarkers 
and possibilities for developing new biomarkers to capsaicinoids, 
chloropicrin, and sulfur mustard for exposure biomonitoring. Also, 
any ideas for early effect biomarkers considering the need for stud-
ies on subchronic and chronic toxicity would be very useful. Special 
emphasis is given on any existing human data.
CapsaICINOIDs
Capsaicinoids  are  components  in  hot  pepper  plants,  genus 
Capsicum sp. Six naturally occurring components, i.e., capsaicin, 
dihydrocapsaicin, nordihydrocapsaicin, homocapsaicin, homodi-
hydrocapsaicin, and nonivamide have been identified in pepper 
products. Capsaicinoids belong to a group of vanillyl fatty acid 
amides. The characteristic structure of a capsaicinoid analog has 
a vanillamide moiety (4-hydroxy-3-methoxybenzylamide) and an 
acyl chain containing 10–11 carbon atoms (Table 1; Cordell and 
Araujo, 1993; Surh and Lee, 1995). Capsaicin and dihydrocapsaicin 
are the principal and most abundant analogs constituting approxi-
mately 60–90% of the total capsaicinoid concentration in the natu-
ral pepper products and the remainder (10–40%) is combination 
of other analogs (Cordell and Araujo, 1993; Reilly et al., 2001).
Capsaicinoids are used for many purposes, particularly as spices 
(Cordell and Araujo, 1993). Interesting from toxicological point of 
view is their use as irritating ingredients in “pepper gas” sprays or 
Table 1 | Chemical and physical properties of sulfur mustard, capsaicin, and chloropicrin.
  Agent
Property/parameter  Sulfur mustard2,3  Capsaicin3,4  Chloropicrin3,5,6
Chemical formula  C4H8Cl2S  C18H27NO3  CCl3NO2
Structure     
Form at rt.  Yellowish greasy oil, vesicant  Crystalline off-white powder, irritant  Colorless liquid, irritant
CAS no.  505-60-2  404-86-4  76-06-2
Molecular weight  159.1 g/mol  305.4 g/mol  164.4 g/mol
Melting point  13.5°C  65°C  −64°C
Boiling point  216°C  210–220°C  112°C
Density (liquid)  1.27 g/cm3 (at 20°C)  1.04 g/cm3 (at 25°C)  1.64 (at 20°C)
Vapor pressure (mmHg 20 or 25°C)  0.11 mmHg (at 25°C)  1.3 × 10−8 mmHg (at 25°C)  23.8 mmHg (at 25°C)
Vapor density (air = 1)  5.5  1.59  5.7
Water solubility (g/l)  0.068 g/l (at 25°C)  Poor  1.62 g/l (at 25°C)
Henry’s law constant1  2.45 × 10−5 atm m3/mol  1.0 × 10−13 atm m3/mol  0.00205 atm m3/mol
Log Pow (octanol–water partition)  2.41  3.04  2.09
LD50  2.4 mg/kg (oral, rat)  47.2 mg/kg (oral, mouse)  250 mg/kg (oral, rat)
1Henry’s law p = kHc, where p is the partial pressure of the solute, c is the concentration of the solute and kH is a constant with the dimensions of pressure divided 
by concentration.
2Munro et al. (1999).
3Hazardous Substances Data Bank, HSDB (2009).
4Yaws (2008).
5Jackson (1933).
6Sanchez-Moreno et al. (2009).www.frontiersin.org  December 2010  | Volume 1  | Article 140  |  3
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et al., 2003a; Reilly and Yost, 2006). Thus, reactive metabolites 
formed by CYP-mediated metabolism of capsaicin may increase 
toxicity particularly in tissues, where protective systems against 
reactive metabolites are weak. However, the reactive metabolites 
formed from CYP-enzymes are probably not the only reason for 
toxicity by capsaicinoids. The studies on capsaicinoid metabolism 
have focused mainly on CYP-metabolism. It would be important 
to gain more information on potential damage to DNA or other 
macromolecules in the commonly exposed tissues.
GeNeRal TOxICITy
Capsaicinoids have multiple effects extending from mild irrita-
tion to severe toxic effects in various tissues. The main source of 
adverse human exposures to capsaicinoids is pepper spray aerosols. 
Exposure can be highly toxic if the pepper spray is used in closed 
places, e.g., inside a house. Pepper spray induces inflammation 
in the skin, eyes, and epithelia of the airways leading to swelling 
of capillaries in the exposed tissues. The effects on eyes result in 
copious lacrimation, pain, immediate closure of the eyes (blepha-
rospasm), and temporary blindness. In the skin, capsaicinoids cause 
an intense burning pain sensation, vasodilatation, erythema, and 
subsequent desensitization of the exposed skin area. The symp-
toms are generally brief and disappear within 2 h (Busker and van 
Helden, 1998).
The major responses to an acute exposure of pepper spray can 
be found in pulmonary system. Capsaicin-sensitive sensory nerves 
innervate all levels of the respiratory tract and are widely distrib-
uted also in the cardiovascular system. The capsaicin activated 
sensory nerves are associated with initiation of many reflexes in 
pulmonary system, i.e., mucus hypersecretion, cough, bronchoc-
onstriction, and sensation of dyspnea (Lee and Pisarri, 2001). 
Low concentrations of capsaicinoids induce coughing and sneez-
ing, while higher doses can lead to bronchoconstriction, mucosal 
edema, and dyspnea (Collier and Fuller, 1984; Fuller, 1990). The 
mechanism of bronchoconstriction and airway mucosal edema 
seen in laboratory animals and humans has been explained by 
capsaicin-induced release of neuropeptides, particularly substance 
P and promotion of proinflammatory cytokine production (e.g., 
IL6, IL8, tumor necrosis factor-α), which lead to inflammation 
in respiratory tissue (Lundberg et al., 1983; Veronesi et al., 1999; 
Reilly et al., 2003b). High doses of capsaicin containing sprays or 
other capsaicin-products may be risk particularly for children, 
asthmatics, and for the patients suffering from cardiovascular 
diseases (Doherty et al., 2000; Geppetti et al., 2006). The airway 
resistance and other respiratory problems have been the most seri-
ous symptoms in children and adults after inhaling high concen-
trations of pepper products (Watson et al., 1996; Miller, 1996). 
Respiratory symptoms and changes in pulmonary functions have 
also been reported in hot pepper workers (Blanc et al., 1991). 
However, chronic effects of low-dose inhalation of capsaicinoids 
are not well known.
In  animal  studies,  capsaicinoids  (by  nose-only  inhalation, 
approximately 1.0–1.2 mg/kg for 30 min) produce marked acute 
inflammation, epithelial cell dysplasia, and necrosis in the upper 
and lower respiratory tract. The lesions can be particularly severe in 
the terminal bronchioles and alveoli where the capsaicinoids cause 
epithelial cell injury, and mild and marked vascular congestion with 
TOxICOkINeTICs
A few studies on absorption and elimination of capsaicinoids in 
humans are available. Recently, Babbar et al. (2009) exposed human 
subjects for 60–90 min using high-concentration capsaicin skin 
patches (640 μg/cm2). Skin absorption of capsaicin was low and 
elimination rate from the plasma rapid. The maximal plasma con-
centration reached 17.8 ng/ml and the estimated mean elimina-
tion half-life in the plasma was 1.64 h. Human stratum corneum 
may restrict permeation of capsaicin (Pershing et al., 2004; Babbar 
et al., 2009). In vitro permeation studies of topical capsaicin indicate 
that human and pig skin have rather similar rates of absorption 
whereas the skin of rat, mouse, and rabbit are more permeable 
(Fang et al., 1995).
In animal models, capsaicinoids (capsaicin and dihydrocapsai-
cin) have been shown to absorb readily from the gastrointestinal 
tract (85% absorbed in 3 h). They are further extensively metabo-
lized in the liver before reaching the general circulation. Excretion 
in free and glucuronide conjugates in urine and feces has been dem-
onstrated (Saria et al., 1982; Kawada et al., 1984; Donnerer et al., 
1990). After intravenous (2 mg/kg) and subcutaneous (50 mg/kg) 
administrations, unchanged capsaicin is distributed to the brain, 
spinal cord, blood, kidney, and liver within 3–10 min. Later on, the 
level quickly decreases in blood and liver while being still high in the 
brain and spinal cord (Saria et al., 1982; Donnerer et al., 1990).
Studies, using microsomal, and S9-fractions from humans and 
other species, or recombinant cytochrome P450 enzymes (CYP-
enzymes) have shown efficient metabolism of capsaicin by hepatic 
enzymes but less efficient by enzymes from the extrahepatic tissues 
like skin and respiratory tract (Reilly et al., 2003a; Reilly and Yost, 
2006; Chanda et al., 2008). Early studies demonstrated that cap-
saicin is converted to hydroxylated metabolites through aromatic 
and alkyl side chain hydroxylation and modifications of these struc-
tures were suggested to reduce its biological activity (Surh et al., 
1995; Surh and Lee, 1995). Later on, Reilly et al. (2003a), using cell 
fractions from human liver and respiratory tract and combination 
of LC/MS, LC/MS/MS and LC/NMR techniques identified nine 
capsaicin metabolites. These were generated by aromatic and alkyl 
hydroxylation, O-demethylation, N-alkyldehydrogenation and ring 
oxygenation of capsaicin. Several CYP-enzymes (CYP1A1, 1A2, 
2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4) were demonstrated to 
catalyze these reactions. The metabolite patterns formed by human 
liver and lung microsomal fractions were similar but the overall 
rate of capsaicin metabolism was markedly less by lung than liver 
microsomal fraction (Reilly et al., 2003a; Reilly and Yost, 2006).
Capsaicin  was  metabolized  by  CYP-enzymes  also  to  elec-
trophilic, reactive metabolites that produce adducts with GSH and 
inhibited CYP2E1 and possibly some other CYP-enzymes (Reilly 
et al., 2003a). The studies by Reilly et al. (2003a) also implicated 
CYP-mediated formation of quinone methide metabolite at the 
4-OH-group of the vanilloid ring. The mechanism by which qui-
nones could produce deleterious effects is by alkylation of pro-
teins and DNA, depletion of GSH or by the formation of reactive 
oxygen species (ROS; Bolton et al., 2000). On the other hand, 
metabolism  of  capsaicinoids  may  also  diminish  their  toxicity 
as shown in cell culture studies. Inhibition of CYP-dependent 
metabolism of capsaicin by the common CYP inhibitor (1-ami-
nobenzotriazole) increases toxicity in liver and lung cells (Reilly Frontiers in Pharmacology  |  Predictive Toxicity    December 2010  | Volume 1  | Article 140  |  4
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2000; Mezey et al., 2000; Ständer et al., 2004). However, it is not 
clear whether the function of this receptor in non-neuronal tissues 
or in the central nervous system is similar as in sensory neurons 
or whether it is involved in the effects of capsaicinoids. In any case 
sensory neurons are about an order of magnitude more sensitive 
to capsaicinoids than non-neuronal cells (Holzer, 1991).
Stimulation of sensory neurons by capsaicin causes vanilloid 
receptor mediated influx of extracellular calcium and release of 
intracellular calcium from the endoplasmic reticulum (Caterina 
et al., 1997; Karai et al., 2004). This releases neuropeptides such as 
substance P, calsitonin-gene-activated peptide (CGRP), and neu-
rokinin A from peripheral nerve terminals. These bioactive com-
pounds are important in the communication of primary sensory 
neurons with other cells. Various immune, smooth muscle, and 
endothelial cells are known to respond to these neuropeptides and 
mediate neurogenic inflammation (Richardson and Vasko, 2002). 
Change of calcium homeostasis by prolonged or excessive activa-
tion of TRPV1-receptor is probably the main cause for neurotox-
icity indicated by swelling of mitochondria and degeneration of 
the neurons (Szallasi and Blumberg, 1999; Hiura et al., 2002). Cell 
culture studies have shown that capsaicin elevated intracellular 
calcium causes mitochondrial membrane permeability transition, 
ROS-formation, and DNA fragmentation. Mitochondrial dysfunc-
tion and mitochondrial-derived caspases have been suggested to 
be the mechanism of apoptotic cell death in the sensory neurons 
(Shin et al., 2003). In addition to mitochondrial dysfunction, endo-
plasmic reticulum stress (ER-stress) or reduction of endoplasmic 
reticulum functions have been suggested to increase apoptosis in 
bronchial epithelial and lung epithelial fibroblast cells following 
treatment with capsaicin (Thomas et al., 2007; Oh and Lim, 2009). 
Under ER-stress, the efficiency of protein-processing decreases and 
unfolded proteins accumulate in the ER lumen leading ultimately to 
apoptotic cascades (Kaufman, 2002). Mitochondria- and ER-stress-
mediated apoptosis has also been proposed as a mechanism for 
cell death in human prostate and breast cancer cell lines following 
capsaicin treatment (Sanchez et al., 2008; Lee et al., 2009).
Some effects of capsaicinoids are probably not mediated via 
TRPV1 receptor. The effects in non-neuronal tissues do not generally 
show desensitization like the responses in sensory neurons (Holzer, 
1991). Capsaicin has been shown, e.g., to decrease mitochondrial 
membrane potential and release cytochrome c (Athanasiou et al., 
2007), to change plasma membrane fluidity and structure (Aranda 
et al., 1995) to promote lipid peroxidation (Richeux et al., 2000), to 
inhibit the plasma membrane electron–transport system (NADH-
oxidoreductase) and to promote the generation of ROS in various 
cell lines (Wolvetang et al., 1996; Macho et al., 1999). However, 
it is not known whether metabolic intermediates or the parent 
compound are responsible for these effects.
ChlOROpICRIN
Chloropicrin (trichloronitromethane) is a lung irritant and strong 
lacrimator (Table 1). It is a volatile liquid at room temperature and 
standard pressure, and decomposes at high temperatures forming 
toxic gases such as phosgene, nitrogen oxides, and nitrosylchloride. 
Because of its strong irritating property it was used in combination 
with other war gases as a harassing and casualty agent in the World 
War I (Sutherland, 2008). Today chloropicrin is used particularly as 
alveolar hemorrhage (Reilly et al., 2003b). The doses used by Reilly 
et al. (2003b) were estimated to be about the same as humans could 
receive during 5–10 s exposures to pepper spray.
Capsaicinoids have been known to act selectively on the small 
diameter  primary  sensory  neurons  (C-  and  Aδ).  Irritation  of 
these capsaicin-sensitive neurons, which originate from the dor-
sal root, trigeminal, and nodose ganglia (Holzer, 1991; Szallasi and 
Blumberg, 1999) results in an initial burning sensation and a period 
of enhanced sensitivity to painful thermal and mechanical stimuli. 
This is followed by inactivation or desensitization (defunctionaliza-
tion) during which an individual is relatively resistant to capsaicin 
or other painful stimuli. Defunctionalization can be reversible but 
can also be followed by morphological changes or neurotoxicity 
and loss of a subpopulation of small sensory neurons (see Holzer, 
1991; Caterina and Julius, 2001).
Neurotoxicity of capsaicin is dependent of the developmental 
stage. When capsaicin is administrated (50 mg/kg s.c. in rat) at 
neonatal stage, it acts as a neurotoxin and destroys terminal parts 
of the sensory neurons supplied by vanilloid receptors and induces 
long-lasting mitochondrial swelling in the soma (see Holzer, 1991; 
Hiura et al., 2002). As adults these animals are unresponsive to 
capsaicinoids (see Holzer, 1991; Hiura 2000; Caterina and Julius, 
2001). The toxicity of capsaicin on developing neurons has been 
explained by the inhibition of axonal transport of nerve growth 
factor (NGF). NGF can prevent the neuronal loss, but it does not, 
however, repair damaged mitochondria (Szöke et al., 2002). In adult 
rats, degeneration of primary sensory neurons of dorsal root and 
nodose ganglia by capsaicin has also been demonstrated (Jancsó 
et al., 1985; Czaja et al., 2008). However, adult rats show neuronal 
recovery that can last for several weeks or months (Holzer, 1991; 
Czaja et al., 2008).
In addition to itching and burning pain sensation, in humans, 
repeated topical application of capsaicin (0.075% four times per 
day for 3 weeks) produces decreased sensitivity to mechanically and 
heat induced pain. This is followed by degeneration of epidermal 
nerve fibers, as revealed by histological studies (Nolano et al., 1999). 
The degeneration of epidermal nerve fibers is, however, local and 
presumably only in those nerve fibers that came in contact with 
capsaicin. As in animal studies, limited re-innervations of epidermis 
and partial return of sensation was seen 6 weeks after the treatment 
(Nolano et al., 1999).
MeChaNIsMs Of TOxICITy
The molecular mechanism(s) involved in the action of capsaici-
noids are complex cascades of reactions, which can end up in necro-
sis or apoptosis. The mechanisms are associated with the vanilloid 
or capsaicin receptor (transient receptor potential vanilloid type 1 
receptor, TRPV1) that is predominantly expressed in the primary 
sensory neurons and known to be involved in various physiological 
functions, e.g., inflammation and painful stimuli (for review see 
Holzer, 2008). The TRPV1-receptor is a non-selective cation chan-
nel that is activated by acidosis (protons), heat (>42°C) and various 
chemicals, the best-known activator being capsaicin (Caterina et al., 
1997; Szallasi et al., 2007). TRPV1-receptor has been found also in 
many other tissues, e.g., in the central nervous system, epithelial 
cells in urinary bladder, keratinocytes, cells of the gastric mucosa, 
and mast cells of the skin (Szallasi and Blumberg, 1999; Hayes et al., www.frontiersin.org  December 2010  | Volume 1  | Article 140  |  5
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in vivo. According to their results, toxicity of chloropicrin was due to 
the parent compound or metabolites other than the dechlorinated 
ones (CHCl2NO2, CH2ClNO2) and may be associated with inhibition 
of pyruvate dehydrogenase complex and elevated liver oxyhemo-
globin. Chloropicrin was also shown to react with sulfhydryl groups 
of hemoglobin and decreasing thereby oxygen transport but this is 
not, according to Sparks et al. (2000), the main reason for toxicity.
sUlfUR MUsTaRD
Sulfur mustard [bis-2-(chloroethyl)disulfide] is a toxic vesicant 
type of warfare agent (Table 1). It is a colorless oily liquid at room 
temperature but its volatility results in rapid generation of vapors 
that can pass readily through clothing and skin. The hazard of 
human contact is not only with droplets of liquid, but also with 
vapor. In water, sulfur mustard hydrolyzes slowly forming hydro-
chloric acid and thiodiglycol (Watson and Griffin, 1992).
The principal use of sulfur mustard has been as a warfare chemi-
cal and it was first used in the World War I, near Ypres in Belgium. 
After that it has been utilized in several military conflicts, and used 
also against Kurdish civilians in the 1980s, (Watson and Griffin, 
1992; Geraci, 2008). Although sulfur mustard can be lethal (about 
5% of the exposed died during World War I), it is more likely to cause 
severe acute and long-term incapacitating injuries to the exposed 
persons (Watson and Griffin, 1992; Balali-Mood and Hefazi, 2006; 
Kehe et al., 2009b). There is also strong evidence that occupational 
exposure to sulfur mustard can cause cancer particularly in the 
respiratory tract and larynx area (Easton et al., 1988).
Although sulfur mustard is an old chemical, it is still a threat 
to military personnel and civilian population as well as an envi-
ronmental hazard. There are no good antidotes other than decon-
tamination and supportive care to treat the exposed persons. Sulfur 
mustard has been manufactured in large quantities and stored and 
dumped in soil and seas in many areas. In addition to the Iranian 
victims exposed in 1980s, there are several more recent cases of 
human exposure after accidental leakage from old reservoirs and 
stockpiles during the last 10 years (Geraci, 2008).
TOxICOkINeTICs
Sulfur mustard is known to be absorbed through the skin or lungs. 
It is a lipophilic and very reactive chemical and when delivered as 
liquid or vapor, skin is the main route of exposure (Somani and 
Babu, 1989; Geraci, 2008). Applied to the skin, about 80% is evapo-
rated and the remaining 20% penetrates the skin. Around 10% of 
the penetrated sulfur mustard is estimated to remain locally bound 
to skin and the rest transported with the circulation (Somani and 
Babu, 1989). Adipose tissue and particularly the subcutaneous fat 
form probably a depot from which sulfur mustard can be further 
delivered to circulation (Paromov et al., 2007). Chemical analyses 
of tissues from an Iranian soldier who died 7 days after exposure 
to sulfur mustard showed main accumulation in subcutaneous fat, 
brain, kidney, liver, spleen, and lungs (Drasch et al., 1987). Rather 
similar distribution has been seen in rodents after intravenous, 
inhalation, or percutaneous administration (Langenberg et al., 
1998; Maisonneuve et al., 1994).
Davison et al. (1961) administered radiolabeled sulfur mus-
tard (i.v.) to two terminal cancer patients. 80–90% of the radioac-
tivity was cleared from human blood within some minutes after 
a soil fumigant against insects, fungi, and nematodes (Ruzo, 2006). 
Currently the main source for human exposure is occupational via 
inhalation or dermal contact. Another but minor source may be 
chlorination of drinking water (Castro et al., 1983).
The knowledge of human health effects of chloropicrin exposure 
is limited and only a few accidental cases have been reported. The 
main findings of post-mortem examination of exposed victims 
have been severe pulmonary edema and spotty discoloration of the 
skin (Gonmori et al., 1987). Persons living close to the area where 
chloropicrin is used as a fumigant have been reported to suffer 
from symptoms of irritation such as cough, dyspnea, lacrimation, 
pain, burning, and chest pain (ÓMalley et al., 2004).
TOxICOkINeTICs
Metabolism and elimination of chloropicrin is poorly character-
ized in mammals. Sparks et al. (1997, 2000) studied metabolism 
and  interaction  of  chloropicrin  with  biological  thiols  in  mice 
using radiocarbon labeled chloropicrin. This study showed that 
chloropicrin was readily absorbed and distributed, primarily to 
the liver, kidney, and blood after oral or i.p. administration. Over 
50% of administered radiocarbon was found in urine and around 
9% in feces 48 h after the administration. The metabolites iden-
tified were thiophosgene and dechlorination products; dichlo-
ronitromethane (CHCl2NO2) chloronitromethane (CH2ClNO2), 
nitromethane  (CH3NO2),  and  numerous  unidentified  polar 
products. Similarly mouse liver microsomal and cytosolic frac-
tions metabolized chloropicrin rapidly to dechlorinated metabo-
lites and addition of NADPH to the microsomal reaction mixture 
accelerated the formation of these products (Sparks et al., 1997). 
The enzymes responsible for the metabolism are not known but 
CYP, glutathione-S-  transferase, and β-lyase reactions have been 
suggested as the contributing pathways (Castro et al., 1988; Sparks 
et al., 1997, 2000).
TOxICITy aND MeChaNIsM Of aCTION
General effects after chloropicrin exposure are severe irritation 
of the eyes, skin, and mucosal membranes of the respiratory and 
gastrointestinal tracts. Because of its high volatility, the main route 
for human exposure to chloropicrin is inhalation. In addition to 
irritation, acute exposure may cause nausea, vomiting, breathing 
difficulties, and inflammation of the respiratory tract. At severe 
cases, damage in respiratory tract can lead to pulmonary edema 
and death (AEGL, 2008). In vitro testing implicates genetic toxic-
ity in the presence of an exogenous metabolic system or glutath-
ione (Schneider et al., 1999; Kundu et al., 2004; Plewa et al., 2004). 
Mammalian cells in vitro have shown some evidence of a clastogenic 
effect (Garry et al., 1990). There are no relevant studies on potential 
health effects of low and long-term exposure to chloropicrin.
Very little is known of the molecular mechanisms of chloropi-
crin. It has been shown to form protein adducts with thiol groups 
(e.g., Hb-SH; Sparks et al., 2000). The early work by Mackworth 
(1948) suggests that lachrymators like chloropicrin act by inhibit-
ing thiol-containing enzymes such as succinate dehydrogenase and 
pyruvic oxidase, enzymes, which play an important role in energy 
metabolism. Later on, Sparks et al. (1997, 2000) studied chloropicrin 
reaction with thiols and its glutathione-mediated metabolism to 
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pseudomembranes, which can lead to edema and secondary infec-
tions. Delayed effects include chronic obstructive pulmonary dis-
eases, bronchiectasis, pulmonary fibrosis, and lung and pleural 
cancer (Ghanei and Harandi, 2007; Rowell et al., 2009).
High doses of sulfur mustard absorbed systemically can cause 
permanent damage particularly in proliferating tissues like bone 
marrow, lymphoid tissue, and the intestinal tract (see Balali-Mood 
and Hefazi, 2006; Rowell et al., 2009). Examination of sulfur mus-
tard-victims have shown a decrease in the number of leucocytes, 
depression of cell mediated immunity and anemia (Balali-Mood 
and Hefazi, 2006). Sulfur mustard is classified as carcinogenic to 
humans (class 1) by the International Agency for Research on 
Cancer (IARC, 1975).
pROpOseD MeChaNIsMs Of TOxICITy
Sulfur mustard is a reactive chemical causing disruption and com-
plex impairment of a variety of cellular functions (see reviews by 
Paromov et al., 2007; Kehe et al., 2009b; Shakarjian et al., 2010). 
Proliferating epithelial cells are the cell type with the highest sus-
ceptibility to sulfur mustard-induced toxicity in primary target 
tissues eyes, skin, and respiratory tract. Many studies provide evi-
dence that acute toxicity of sulfur mustard is related to its alkylating 
capacity, and ability to induce oxidative stress and inflammation 
in affected tissues. These events in turn cause detrimental changes 
in metabolic, genetic, and other cellular functions leading to cell 
death by apoptosis or necrosis (Papirmeister et al., 1985; Paromov 
et al., 2007; Kehe et al., 2009b).
The strong reactivity of sulfur mustard is due to ionization of 
its chlorine atoms that can lead to the formation of an ethylene 
sulfonium ion intermediate and carbonium ion. These are strong 
alkylating agents, which react with cellular nucleophilic centers 
(-SH, -NH2- groups) in DNA, RNA, proteins, and lipids (Somani 
and Babu, 1989; Dacre and Goldman, 1996). Several studies have 
shown that sulfur mustard can modify DNA through the formation 
of DNA mono-adducts and DNA cross-links and thus inhibit cell 
division (Fidder et al., 1994; Lundlum et al., 1994).
DNA alkylation is considered as the primary alteration of sulfur 
mustard toxicity, which then leads to further changes in cellular func-
tions. DNA-damage activates DNA-repair mechanisms, particularly 
poly(ADP-ribose) polymerase (PARP; Papirmeister et al., 1985). The 
repair reactions, which use β-nicotinamide adenine dinucleotide 
(NAD+) as a substrate, deplete cellular NAD+ stores. Since NAD+ is 
an important cofactor in the glycolysis and tricarboxylic acid cycle, 
this leads to impairment of energy production. Increase of ROS, nitric 
oxide, and peroxynitrite concentrations, i.e., oxidative stress has also 
been reported to be an important initial effect. The disturbance of 
proper oxidation–reduction potential leads to lipid peroxidation that 
further contributes damage in the exposed cells (Gross et al., 1993; 
Paromov et al., 2007). In addition, activation of several inflammatory 
mediators (proinflammatory cytokines, eicosanoids), release of tissue 
proteases (matrix metalloproteases), and change of calcium balance 
in cells have been shown to be important in blister formation, and 
epidermal–dermal separation in skin toxicity (Arroyo et al., 2000; 
Mol et al., 2009; Ruff and Dillman, 2010).
Although the exact mechanisms underlying chronic toxicity of 
sulfur mustard are not clear, it is apparent that the events in acute 
toxicity are related to long-term toxicity. Some studies suggest 
  administration. The residual level in plasma remained constant at 
least for 2 days, suggesting binding to some blood constituents. The 
metabolites excreted were present mainly as conjugates. The major-
ity of radioactivity, excreted in urine was suggested to represent 
compounds formed from alkylation by sulfur mustard, rather than 
metabolites from enzyme action (Davison et al., 1961). However, 
it is unclear how this reflects events in healthy people, e.g., liver 
metabolism. Chemical analysis of urinary metabolites and adducts 
with macromolecules from rodents (Black et al., 1992) and humans 
(Davison et al., 1961; Black and Read, 1995; Barr et al., 2008) sug-
gest that sulfur mustard is metabolized by hydrolysis, oxidation, 
conjugation with glutathione, and β-lyase reactions. As shown by 
Davison et al. (1961) with the cancer patients, the main metabolites, 
thiodiglycol sulfoxide, and two β-lyase metabolites in urine have 
also been found from casualties of sulfur mustard (Black and Read, 
1995; Read and Black, 2004; Barr et al., 2008).
GeNeRal TOxICITy
The data from both animal and human exposures show that sulfur 
mustard is extremely toxic through all routes of exposure causing 
severe lesions in multiple organs at very low doses (Dacre and 
Goldman, 1996). The immediate tissues affected are the eyes, skin, 
and respiratory tract. Extensive exposure leads also to systemic 
effects;  these  include  the  gastrointestinal  tract,  hematopoietic 
and lymphoid tissues and nervous system. The effects generally 
increase with increasing temperature and humidity (Watson and 
Griffin, 1992; Balali-Mood and Hafazi, 2006). In addition to acute 
toxicity, delayed chronic responses occur several months or years 
(even 15–20 years) after a single exposure. At present, about 45,000 
Iranians, exposed in the 1980s, are reported to suffer from delayed 
adverse effects of sulfur mustard (Kehe et al., 2009a; Ghanei and 
Harandi, 2007; Rowell et al., 2009). However, there is no data about 
the putative effects of a long low-dose exposure.
Eyes are the most sensitive organs to the acute effects of sulfur 
mustard. The moist mucous surface of the cornea and conjunctiva, 
as well as high metabolic activity of corneal epithelial cells contrib-
ute to the sensitivity of eyes to sulfur mustard. Mild and moderate 
exposure to vapor or liquid causes irritation, lacrimation, burning, 
swollen eyelids, blepharospasm, and temporary blindness. Severely 
injured victims have corneal lesions with destruction of blood ves-
sels, hemorrhages, opacity, and ulceration. Severely injured eyes 
may develop delayed keratopathy that leads to blindness (Solberg 
et al., 1997; Baladi-Mood and Hefazi, 2006).
Skin exposure results in erythema, edema, and blistering. Moist 
parts of the body (underarms, neck, and back) are generally most 
affected (Kehe et al., 2009a). Histological studies of lesions have 
shown degenerative changes particularly in the basal keratinocytes 
of epidermis and separation of epidermis from dermis (Sabourin 
et al., 2000; Smith et al., 1998). The lesions heal slowly and blis-
ters may ulcerate promoting secondary infections (Paromov et al., 
2007). In the skin as in the eyes, late toxic effects include hyper- 
or hypopigmentation, atrophy, keratitis, and chronic neuropathic 
symptoms (Balali-Mood and Hefazi, 2006).
All parts of the respiratory tract are vulnerable to sulfur mustard 
vapor (see Balali-Mood and Hefazi, 2006). Inhalation causes inflam-
mation in the upper and lower respiratory tract that can progresses 
over several days. High doses cause primarily bronchospasm and www.frontiersin.org  December 2010  | Volume 1  | Article 140  |  7
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matrix, like tissue, urine, or blood. These different matrixes have 
different implications as to the timing of exposure. Urinary metabo-
lites are usually short-lived and only reflect acute exposure (Watson 
and Mutti, 2004), whereas adducts in tissue or blood cells may be 
retained as long as the cells live. DNA-adducts in white blood cells 
implicate longer-term exposure, and hemoglobin-adducts in red 
blood cells reflect more chronic exposure considering that the life 
span of red blood cells is over 100 days. Advantage of the protein 
adducts is that they have a longer life span than DNA-adducts. They 
are generally more stable and have the same lifetime as the native 
proteins. For instance the half-life of human albumin is 20–25 days 
and hemoglobin 120 days, respectively (Törnqvist et al., 2002).
In pepper products, capsaicin and dihydrocapsaicin together 
constitute 60–90% of capsaicinoids. Both of them can be detected 
by LC–tandem MS in blood of treated rats (Reilly et al., 2002). 
Unfortunately, only anecdotal studies reporting human blood or 
urinary levels of capsaicinoids exist (Babbar et al., 2009). Thus, 
no biomarkers or validated methods for such markers as to cap-
saicinoid exposure exist. Stratum corneum of the human skin is 
known to serve as an efficient barrier to the absorption of chemicals. 
According to Pershing et al. (2004) this applies also to capsaicinoids, 
which are lipid soluble. They found the half-life of capsaicinoids 
to be about 24 h in stratum corneum, which probably explains the 
re-emergence of symptoms with heat or water-exposure after the 
acute phase. Skin cells may be a useful tissue for exposure monitor-
ing of capsaicinoids.
Quantifying  nitromethane,  a  metabolite  of  chloropicrin 
(trichloronitromethane) has been proposed as an indicator of 
chloropicrin exposure (Alwis et al., 2008). Halonitromethanes are 
spontaneously dehalogenated in blood and nitromethane is the 
endproduct. However, nitromethane may also be formed endog-
enously from peroxynitrate, and thus this metabolite is not specific 
for chloropicrin. The only known metabolic pathway in mammals 
is conversion of chloropicrin to raphanusamic acid via thiophos-
gene intermediate. Raphanusamic acid (Figure 1), which is a cyclic 
cysteine adduct, was found in urine of chloropicrin-exposed mice 
by GC–MS (Sparks et al., 2000). Whether this metabolic route exists 
in humans remains to be seen. Thus, it will require further work 
before useful exposure biomarkers for chloropicrin have been iden-
tified and validated for its meant use.
Several metabolites and adducts with proteins and DNA have 
been suggested as biomarkers of exposure to sulfur mustard (for 
a recent review see Black, 2008). The major urinary metabolites 
of sulfur mustard are derived from hydrolysis, oxidation or con-
jugation  with  glutathione.  Gas  chromatography–tandem  mass 
spectrometry (GC–MS/MS) and liquid chromatography–tandem 
mass spectrometry (LC–MS–MS) methods have been developed 
and used for the detection of two closely related urinary β-lyase 
metabolites and their common reduction products (Table 2) in 
exposed rats and human casualties (Black and Reed, 1995; Read and 
Black, 2004). These metabolites in urine are regarded as potentially 
good and specific markers for exposure since they can be present 
at high concentrations in exposed persons but are not found in 
control persons.
In  addition  to  beta-lyase  metabolites,  two  other,  the  major 
hydrolysis products, thiodiglycol, and its subsequent oxidation 
product, thiodiglycol sulfoxide (Table 2) are abundant in human 
autoimmune basis for the cause of chronic toxicity. Sulfur mustard 
alters proteins resulting in protein-sulfur mustard products that 
may stimulate autoimmune reactions in exposed tissues (Solberg 
et al., 1997; Javadi et al., 2005). Also, high level of inflammatory 
cytokines after the initial injury can hinder apoptosis of polymor-
phonuclear leukocytes, thus increasing their active lifespan and 
contributing to the chronic tissue damage (Asensi et al., 2004). 
Furthermore,  toxicity  of  free  radicals  and  other  degenerative 
changes after the initial injury have been proposed as causes of 
chronic effects (Aasted et al., 1987; Hosseini-Khalili et al., 2009; 
Ghanei and Harandi, 2010). Recently, Hosseini-Khalili et al. (2009) 
showed mutations in the tumor suppressor gene, TP53, when char-
acterizing lung cancer in mustard gas victims from the Iran–Iraq 
war. These mutations included similar types of point mutations 
as found in factory workers chronically exposed to sulfur mustard 
(Takeshima et al., 1994) implicating TP53 mutations as a biomarker 
(Vähäkangas, 2003).
Experimental in vivo rabbit studies (Kadar et al., 2009) suggest 
that the chronic lesions in the eyes, leading later to epithelial defect, 
and visual impairment, are due to epithelial stem cell degenera-
tion. This may be based on prolonged impaired corneal innerva-
tion and chronic inflammation, associated with increased activity 
of matrix metalloproteinases. In rabbit eyes, protease inhibitors 
attenuate acute injury, and postpone the delayed toxicity (Kadar 
et al., 2009).
pOssIbIlITIes fOR bIOMaRkeRs aND bIOMaRkeR 
DevelOpMeNTs
A  biomarker  is  a  distinctive  biological  or  biologically  derived 
indicator (e.g., a metabolite) of a process, event, or condition (see 
Hecht, 2008). Various types of biomarkers for toxic agents have 
been developed, including biomarkers of exposure, e.g., lead in 
blood (Barbosa et al., 2005), and biomarkers for early effects, e.g., 
micronuclei in peripheral blood lymphocytes indicating damage 
by genotoxic agents (Decordier et al., 2009). The objective to use 
biomarkers of exposure is to increase the accuracy of exposure 
evaluation (Phillips, 2008). To verify exposure and to link the 
exposure with putative health effects of harmful agents, good vali-
dated biomarkers of exposure are essential. For the development 
of exposure biomarkers for specific compounds, mechanistic, and 
toxicokinetic information of the compound is the basis.
Biomarkers of exposure can be developed based on the com-
pound itself or its metabolites in body fluids, or tissue bound 
products, e.g., protein and DNA-adducts (Vineis and Perera, 2000, 
2007). Tissue responses to the chemical like an increase in serum 
enzyme-activities (alanine aminotransferase) in connection with 
drug-induced liver damage may also serve as an exposure biomarker 
(Ozer et al., 2008). In the development of biomarkers, as important 
as the relevance of the putative biomarker is the analytical tech-
nique for its detection and finally validation of the biomarker for 
its purpose. This step-wise development and validation of both 
the analytical method (reproducibility, accuracy, sensitivity, and 
specificity) and the biomarker (e.g., inter- and intraindividual vari-
ability and confounding factors) in molecular epidemiology studies 
separately is the prerequisite for a routinely usable biomarker (see 
e.g., Vineis and Garte, 2008; Vähäkangas, 2008). Furthermore, it has 
to be shown that the analytical method works in available biological Frontiers in Pharmacology  |  Predictive Toxicity    December 2010  | Volume 1  | Article 140  |  8
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Table 2 | Metabolites and adducts suggested as exposure biomarkers for sulfur mustard.
Possible biomarker  Structure  Sampling  Reference
β-lyASe MeTAboliTeS 
1-Methylsulfinyl-2-[2-(methylthio)    In vivo: detected in human urine 2–11  Read and Black (2004),  
ethylsulfonyl]ethane (MSMTESE)    days after exposure to sulfur mustard (SM)  Barr et al. (2008)
1,1′-Sulfonylbis-[2-(methylsulfinyl)        
ethane] (SBMSE)
HydRolySiS And oxidATion PRoduCTS
Thiodiglycol (TDG)    In vivo: detected in human urine 1–11  Jakubowski et al. (2000),  
   days after exposure to SM  Riches et al. (2007)
Thiodiglycol sulfoxide (TDGO)     
HeMoglobin AdduCT:
N-HETE-valine    In vivo: detected in rat blood 28 days after the  Black et al. (1997),  
   (i.v.) exposure to SM, found also in the blood  Noort et al. (2008) 
    from human casualties of sulfur mustard poisoning
AlbuMin AdduCT
S-HETE-Cys-Pro-Phe    In vivo: detected in human blood 8–9  Noort et al. (1999, 2008) 
   days after the exposure to SM,  
    and in rat blood 7 days after the exposure
dnA-AdduCT
N7-HETE-Gua    In vivo: detected in urine from guinea  Fidder et al. (1996) 
   pigs 34–48 h after (i.v.) expose to SM
KeRATin AdduCT
Nω-HETE-glut or Asp    In vivo: detected in human skin  van der Schans et al. (2002)
FiguRe 1 | Raphanusamic acid, a metabolite found in mice urine after 
exposure to chloropicrin.
urine exposed to sulfur mustard (Jakubowski et al., 2000; Riches 
et al., 2007). Although high levels in urine provide evidence of 
exposure to sulfur mustard, disadvantage is that low level (<2 ng/
ml), of thiodiglycol sulfoxide is present in non-exposed human 
urine (Riches et al., 2007). It is also not known, if ethnic back-
ground, food supply or other life style factors could contribute to 
thiodiglycol sulfoxide levels in the urine. All these aspects need to 
be taken into consideration.
The  primary  alkylation  site  of  DNA  by  sulfur  mustard 
is  the  N7-position  of  deoxyguanosine  leading  to  the  for-
mation of N7-HETE-Guanine adduct (Fidder et al., 1994). 
Experimental studies with guinea pigs have shown that excre-
tion of N7-HETE-Guanine in urine increases within short time 
(2–3 h) after the exposure but decreases rapidly thereafter. On 
basis of this Fidder et al. (1996) proposed the detection of 
N7-HETE-Guanine in urine as suitable to assess acute expo-
sure to sulfur mustard (Table 2). An antibody has been raised 
against this adduct and it has been used in competitive ELISA 
assay to detect the adduct in human white blood cells after 
in vitro treatment (van der Schans et al., 1994). However, no 
human biomonitoring studies exist to verify the usefulness 
of this adduct.
Binding of sulfur mustard to valine or histidine residues of 
hemoglobin (N7-HETE-valine) and a cysteine residue in a digested 
small peptide fragment of albumin (S-HETE-Cys-Pro-Phe) have 
been explored as possible biomarkers for exposure and effect 
(Table 2; Noort et al., 1999, 2008). Gas chromatographic–mass www.frontiersin.org  December 2010  | Volume 1  | Article 140  |  9
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CONClUsIONs
Biomarkers for low-level and long-term exposures of chloropicrin, 
sulfur mustard, and capsaicinoids do not exist so far. However, pos-
sible biomarkers have been suggested especially in the case of sulfur 
mustard, but no routinely usable quantitative biomarkers exist for 
exposure monitoring. The suggested biomarkers of sulfur mustard, 
metabolites, and macromolecular adducts can already be analyzed 
qualitatively.  However,  quantitative  measurements  await  further 
development and validation of the analytical methods especially for 
low exposure level. Studies on the mechanisms of long-term toxicity 
may provide further ideas in addition to the potential metabolism-
based biomarkers. It is essential that potential biomarkers for routine 
use are validated in molecular epidemiology studies.
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spectrometric methods exist and have also been used to qualita-
tively analyze these adducts in blood samples from humans and 
experimental animals exposed to sulfur mustard (Noort et al., 
1999, 2008; Smith et al., 2008). The adducts provide information 
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